Signal active
Organization
Contact Information
Overview
Genomics plc aiming to lead the genomic transformation of healthcare, to develop and apply sophisticated analyses of massive integrated genomic and phenotypic datasets to learn about human biology and reveal the human wiring diagram
They will lead the way through this challenge, using their expertise and experience to unleash the potential of genomics and set the standards by which organisations and patients can benefit from genomic data.
About
Biotechnology, Life Science, Health Care, Medical, Biopharma, Therapeutics, Genetics
2014
101-250
Headquarters locations
Europe
Social
N/A
Profile Resume
Genomics headquartered in Europe, operates in the Biotechnology, Life Science, Health Care, Medical, Biopharma, Therapeutics, Genetics sector. The company focuses on Biotechnology and has secured $30.3B in funding across 224 round(s). With a team of 101-250 employees, Genomics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Genomics, raised $16.2M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
8
5
0
$135.4M
Details
5
Genomics has raised a total of $135.4M in funding over 5 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2018 | Early Stage Venture | 9.1M | ||
2014 | Seed | |||
2024 | Late Stage Venture | 44.6M | ||
2014 | Early Stage Venture | 16.2M |
Investors
Genomics is funded by 46 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Infinity Investment Partners | - | FUNDING ROUND - Infinity Investment Partners | 44.6M |
University of Oxford | - | FUNDING ROUND - University of Oxford | 16.2M |
Genomics | - | FUNDING ROUND - Genomics | 16.2M |
IP Group | - | FUNDING ROUND - IP Group | 16.2M |
Recent Activity
There is no recent news or activity for this profile.